Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Frequently Asked Questions: Broad Agency Announcement (BAA)

The following questions and answers apply to the CHIPS R&D Broad Agency Announcement (BAA), released on September 24, 2025. For questions about the BAA, email research [at] chips.gov (research[at]chips[dot]gov) with “2025-NIST-CHIPS-CRDO-01 Questions” in the subject line.

We will update these FAQs regularly to incorporate answers to new questions we receive. 

For additional guides and materials for CHIPS R&D Funding Opportunities, please click here.

Investment Fund

Establishing the Investment Fund

Why did CRDO establish an Investment Fund under the BAA?

The CHIPS Act (15 U.S.C. § 4656(c)(2)(B)) directs the Department to establish and capitalize an investment fund, in partnership with the private sector, to support startups and collaborations between startups, academia, established companies, and new ventures, with the goal of commercializing innovations that contribute to the domestic semiconductor ecosystem, including:

(i) advanced metrology and characterization for manufacturing of microchips using 3 nanometer transistor processes or more advanced processes; and
(ii) metrology for security and supply chain verification.

What is the key difference between the Investment Fund Path and the R&D Project Path?

Per BAA Section I, CRDO may use the Investment Fund to make awards that are investments in companies, rather than funding specific scientific research and development projects.  CRDO’s objective is to invest in companies that conduct research and prototyping activities, with the goal of eventually commercializing products and services that strengthen the economic competitiveness and security of the domestic semiconductor ecosystem and supply chain.

How does CRDO decide which path an application will be on?

CRDO evaluates White Papers based upon the factors articulated in section V of the revised BAA, and may invite BAA applicants to proceed down the R&D Path or the Investment Fund Path.  White Papers under consideration for the R&D Path are reviewed based on the criteria in section V.1 of the BAA, including whether they have scientific and technical merit and are relevant to national and economic security.  If so, they may be invited to submit a Pre-Negotiation Package.

White papers under consideration for the Investment Fund Path are reviewed based upon the criteria in section V.2 of the BAA, including whether a direct investment in the applicant would be more effective in spurring innovation in the semiconductor ecosystem and whether the investment will support collaborations between startups, academia, established companies, or new ventures. CRDO may request additional information from an applicant after the White Paper submission in order to determine the preferred path.
 

Are there different evaluation criteria for the R&D Project Path and the Investment Fund Path?

Yes. The evaluation criteria for each path are outlined in Section V of the BAA. 

Submission Instructions

Who is eligible?

All applicants eligible for the BAA are considered eligible for the Investment Fund Path or the R&D Project Path. 

Do I have to submit a White Paper through the BAA to be considered for the Investment Fund?

Yes, all applicants must submit a White Paper to the CRDO BAA and follow the BAA submission instructions and package requirements. 

Can I submit a White Paper exclusively to the Investment Fund?

No. The White Paper submission process is the same for the R&D Project Path and the Investment Fund Path.  CRDO will, in its discretion, determine whether an application should be considered for the R&D Path or the Investment Fund Path based upon the evaluation of the White Paper. 

Can I re-submit a previously rejected White Paper to the BAA to be considered for the Investment Fund?

Yes. White Papers that have received a rejection email may re-apply with a modified White Paper and will be considered for the R&D Project path and the Investment Fund path. Applicant organizations may submit more than one White Paper, provided that each White Paper represents a technically distinct project. CRDO will not accept duplicate or overlapping White Papers from a single organization.

If my White Paper was rejected and CRDO requested a resubmission, do I submit the updated White Paper differently to be considered for the Investment Fund?

No. If an applicant received technical feedback from CRDO on their White Paper, they may incorporate the feedback and resubmit their White Paper. The White Paper will be considered for both the R&D Path and the Investment Fund Path.

Where can I go to find more information about the submission process?

To access more information regarding submission instructions and package requirements, click here. The link includes instructions for the R&D path and the Investment Fund Path, with common section at the end.

Consideration of Applications

If I have already applied to the BAA, will my White Paper be considered for the Investment Fund?

CRDO will review and evaluate whether previously submitted applications should be considered for the R&D Project Path or the Investment Fund Path.  For those White Papers that are selected to proceed in the application process, CRDO will communicate to the applicant whether they are being invited to submit an R&D Project Path Pre-negotiation Package or an Investment Fund Path Application.

If I have already received an invitation to submit a PNP, will my application be considered for the Investment Fund Path?

CRDO will review applications previously invited to submit a PNP to determine whether those applications should be considered for the Investment Fund Path. If CRDO determines an applicant is better suited for the Investment Fund Path, that applicant will receive a new invitation to submit an Investment Fund Path Application. If a previously invited applicant does not receive a new invitation, that application will continue as invited on the R&D Project Path.

If, prior to the establishment of the Investment Fund, I received an invitation to submit a Pre-negotiation Package, and then a subsequent invitation to submit an Investment Fund Path Application, do I have a choice to stay on the R&D Project Path?

Yes. In this instance, applicants may choose either the R&D Project Path or the Investment Fund Path. Invitations given prior to the establishment of the Investment Fund will not be rescinded if an applicant chooses to stay on their preferred path. CRDO retains discretion on whether to proceed with an award and on what terms.

If I am selected for one path and I prefer to submit an application to the other path, is that possible?

No. CRDO, at its discretion, will determine the path through which it will consider the application. An applicant may withdraw their application if the offered path is not suitable.

Funding Availability and Agreements

Does CRDO have new funding for the Investment Fund?

No. The total available funding for the CRDO BAA has not changed. The Investment Fund is a portion of the total CRDO budget and funding amounts will be determined by the Department of Commerce. 

Is there a difference in the funding amounts available on a per project basis for the Investment Fund Path and the R&D Project Path?

No. Per the BAA, funding requests must be at least $10 million. The total funding provided will be dependent on the project scope and available funds. 

Will the OT agreement requirements for the Investment Fund Path be different than for the R&D Project Path, to include payment or other ROI requirements?

Yes. The OT agreement requirements will be different depending on the project path. However, CRDO anticipates that awards made pursuant to either path will have a ROI component. Terms and conditions will be negotiated with the applicant on an individual award basis. 

Now that there is an established Investment Fund Path, will applications in the BAA R&D Project Path still need to provide ROI to the government?

Per BAA Section II, as a condition of receiving an award, applicants may be required to issue to the Department equity, warrants, licenses to intellectual property, royalties or revenue sharing, or other such instruments as may be required to ensure a return on investment to the Government. This applies to both BAA paths.  

What is the funding instrument for the Investment Fund?

All awards made under the BAA – irrespective of the path – will be Other Transaction Agreements. 

Will the Investment Fund remain open on the same timeline as the BAA?

Yes. The BAA is the funding announcement that permits CRDO to make awards through the Investment Fund. Applications may be considered for both paths until the BAA has closed.

Submission Process

What is the submission process?

A submission under this BAA consists of a mandatory White Paper and, if invited, a mandatory Pre-negotiation Process. Only those applicants invited to submit a Pre-negotiation Package (after the submission of a White Paper) may submit a Pre-negotiation Package.

Where do I submit a White Paper?

White Papers will only be accepted through Grants.gov. Please note that an active SAM.gov registration is required to submit application materials through Grants.gov. 

Can I submit more than one White Paper?

Applicant organizations may submit more than one White Paper, provided that each White Paper represents a technically distinct project. CRDO will not accept duplicate or overlapping White Papers from a single organization.

I am submitting more than one White Paper, how should I name the files?

Applicant organizations that will be submitting multiple white papers must make separate submissions for each white paper. Applicants must follow all requirements in this document, including naming conventions, for each submission. Applicants should not deviate from these instructions when submitting multiple distinct White Papers.

Do I have to submit a White Paper? Can I immediately submit a Pre-negotiation Package?

White Papers are required. Only those applicants invited to submit a Pre-negotiation Package (after the submission of a White Paper) may submit a Pre-negotiation Package.  Pre-negotiation Packages submitted in the absence of a specific invitation will not be reviewed or evaluated in any way.

Is there a deadline to submit application materials?

Submissions will be accepted until September 30, 2029, unless the BAA is amended to add an earlier closing date. All submissions will be considered on a rolling basis as they are received.

Where can I get additional information?

Before the end of October 2025, CRDO will host an informational webinar to provide general information regarding this BAA, offer general guidance on preparing White Papers and if invited, Pre-negotiation Packages, and answer questions submitted in advance. Proprietary technical discussions about specific project ideas will not be permitted during the webinar. However, questions about this funding opportunity, eligibility requirements, evaluation and award criteria, selection process, and the general characteristics of a meritorious application will be addressed during the webinar and by e-mail for inquiries sent to research [at] chips.gov (research[at]chips[dot]gov) with “2025-NIST-CHIPS-CRDO-01 Questions” in the subject line. 

There is no cost to attend the webinar, but participants must register in advance. Participation in the webinar is not required and will not be considered in the review and selection process. Additional information can be found at http://www.nist.gov/chips/crdo-broad-agency-announcement-baa as it becomes available.

Can I get feedback on my White Paper?

After the review of a White Paper, CRDO may provide technical feedback and request resubmission of White Papers.

Funding

What is the funding instrument for this BAA?

This funding opportunity will result in the award of other transaction agreements, in accordance with 15 U.S.C. § 4659(a)(1).

How much funding will be awarded?

The number of awards is contingent upon the availability of funds and the submission of a sufficient number of meritorious proposals. Project budgets should be at least $10 million and need to reflect the actual needs of the proposed project. All funding considerations are based on the availability of funds.

Is there a cost-sharing requirement?

Cost sharing, as defined in 2 CFR § 200.1, is not required for all awards made under this BAA. However, CRDO may choose to fund only a portion of a project’s total costs, contingent on the recipient demonstrating it has access to sufficient funding to complete the project.

Will there be equity requirements as a part of this award?

As a condition of receiving an award, applicants may be required to issue to the Department equity, warrants, licenses to intellectual property, royalties or revenue sharing, or other such instruments to ensure a return on investment to the Government.

Eligibility

Who is eligible to apply?

Eligible applicants are for-profit organizations; non-profit organizations; accredited institutions of higher education; Federally Funded Research and Development Centers (FFRDCs), and Federal entities (e.g., Federal departments and agencies – see Section III.3). Eligible applicants must be a domestic entity. Individuals and unincorporated sole proprietors are not eligible to receive funding under this BAA. Eligible subawardees include all eligible applicants as well as foreign partners not otherwise prohibited (e.g., foreign adversaries), subject to compliance with specific requirements (see Section VI). CRDO strongly recommends that Federal entities and FFRDCs seeking to respond to this BAA as an applicant first contact the CRDO POC to discuss eligibility; in areas of mutual interest, alternative funding mechanisms may be pursued independent of this BAA.

What is a domestic entity?

For the purposes of this BAA, a domestic entity is an entity (a) organized under the laws of the United States or any jurisdiction within the United States and (b) having a principal place of business in the United States. The principal place of business generally means the place where an entity’s officers direct, control, and coordinate the entity’s activities. A foreign adversary cannot be considered a domestic entity.

General

When is the upcoming informational webinar related to this BAA?

On Wednesday, October 8, 2025, at 2 PM ET, the CHIPS R&D Office (CRDO) will host a pre-recorded, virtual webinar regarding the recently released Broad Agency Announcement. Registration and additional information can be found online here.

This informational webinar will provide general information regarding the CRDO Broad Agency Announcement (BAA) published on September 24, 2025. It will offer general guidance on preparing White Papers and if invited, Pre-negotiation Packages, and answer questions submitted in advance. Proprietary technical discussions about specific project ideas will not be permitted during the webinar. There is no cost to attend the webinar, but participants must register in advance. Participation in the webinar is not required and will not be considered in the review and selection process.

Questions about this funding opportunity, eligibility requirements, evaluation and award criteria, selection process, and the general characteristics of a meritorious application will be addressed during the webinar. Inquiries should be sent by email to research [at] chips.gov (research[at]chips[dot]gov) with “2025-NIST-CHIPS-CRDO-01 Questions” in the subject line no later than October 2, 2025, in order to be addressed during the webinar, as time allows. Questions sent by email to research [at] chips.gov (research[at]chips[dot]gov) with “2025-NIST-CHIPS-CRDO-01 Questions” in the subject line after this date will be answered by email and added to the BAA Frequently Asked Questions page.

How can I schedule a meeting with CHIPS R&D staff to discuss eligibility, areas of mutual interest, submission requirements, and more?

To request a meeting with CHIPS R&D staff, please submit a request via https://askchips.chips.gov/.

My question is not listed above, who should I contact?

Questions about this BAA should be sent to research [at] chips.gov (research[at]chips[dot]gov) with “2025-NIST-CHIPS-CRDO-01 Questions” in the subject line.

For technical assistance with Grants.gov, email support [at] grants.gov (support[at]grants[dot]gov) or call 800-518-4726.

Created September 19, 2025, Updated April 20, 2026
Was this page helpful?